Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04829357 · ClinicalTrials.gov registry record
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
A clinical trial of Stress Urinary Incontinence, sponsored by Ethicon.
- Recruiting
- Registry status
- 195
- Enrollment target
- 4
- Study locations
NCT04829357: Recruiting study of Stress Urinary Incontinence, sponsored by Ethicon.
NCT04829357 is a study of Stress Urinary Incontinence that is actively recruiting participants, run by Ethicon. The registered enrollment target is 195 participants, above the 157-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (24% higher). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04829357, a study of Stress Urinary Incontinence, is actively recruiting participants, sponsored by Ethicon.
- RECRUITING
- Registry status
- 195 participants
- Enrollment target
- 4
- Study locations
Study Summary
The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).
Primary Outcome
Objective cure of Stress Urinary Incontinence (SUI) (treatment success) approximately 5-10 years after surgery, defined as a negative CST
Conditions Studied
Interventions
- DEVICE Intervention
Study Locations (4)
Other
- Bio-Medical University Rome - Rome
- Ospedale San Pietro Fatebenefratelli - Rome
- Ospedale Regionale Beata Vergine - Mendrisio
Pennsylvania
- Institute for Female Pelvic Medicine - North Wales
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2021-09-09 |
| Est. Completion | 2038-12-31 |
What NCT04829357 shows while recruiting
NCT04829357 is an observational study that tracks outcomes without assigning an intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, above the 157-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (24% higher).
The record links to 1 condition, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Intervention is the first listed.
NCT04829357 reports a single indexed study location in Other, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04829357 about?
NCT04829357 is a clinical study titled "Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System". The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT ABBREVO® Continence System in women undergoing Mid-urethral sling surgery for Stress Urinary Incontinence (SUI).
What is the current status of trial NCT04829357?
This trial is currently recruiting. The enrollment target is 195 participants. The study started on 2021-09-09. Estimated completion is 2038-12-31.
What conditions does trial NCT04829357 study?
This clinical trial studies the following conditions: Stress Urinary Incontinence.
What interventions are being tested in trial NCT04829357?
The interventions under investigation include: Intervention (DEVICE).
Who is sponsoring clinical trial NCT04829357?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04829357 being conducted?
This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04829357's enrollment target sits among peer trials
195 8th of 35 higher than 28 of 35 other Stress Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ProACT Post-Approval Study
RECRUITING · NA
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
RECRUITING · NA
-
Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study)
RECRUITING · Phase 4
-
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
RECRUITING
-
Pessary Experience Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
- NCT06008795 · 195 participants · Phase 2
BLOCK-SAH - PPF-Block for Post-SAH Headache
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI